High Point Advisor Group LLC Novartis Ag Transaction History

High Point Advisor Group LLC

$1.67 Billion
Q3 2024

A detailed history of High Point Advisor Group LLC transactions in Novartis Ag stock. As of the latest transaction made, High Point Advisor Group LLC holds 9,094 shares of NVS stock, worth $895,304. This represents 0.06% of its overall portfolio holdings.

Number of Shares

9,094

Previous 9,595 5.22%

Holding current value

$895,304

Previous $1.02 Million 2.35%

% of portfolio

0.06%

Previous 0.06%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$106.13 - $120.89 $53,171 - $60,565	-501 Reduced 5.22%	9,094 $1.05 Million
Q2 2024 Aug 08, 2024	SELL	$92.57 - $107.37 $981,056 - $1.14 Million	-10,598 Reduced 52.48%	9,595 $1.02 Million
Q1 2024 May 14, 2024	BUY	$95.27 - $108.47 $59,543 - $67,793	625 Added 3.19%	20,193 $1.95 Million
Q4 2023 Mar 26, 2024	BUY	$92.27 - $101.54 $132,315 - $145,608	1,434 Added 7.91%	19,568 $1.98 Million
Q2 2022 Aug 15, 2022	SELL	$80.52 - $93.75 $326,428 - $380,062	-4,054 Reduced 18.27%	18,134 $1.52 Million
Q3 2021 Nov 15, 2021	SELL	$81.78 - $95.14 $268,565 - $312,439	-3,284 Reduced 12.89%	22,188 $1.82 Million
Q2 2021 Jul 29, 2021	BUY	$85.24 - $94.15 $10,058 - $11,109	118 Added 0.47%	25,472 $2.32 Million
Q1 2021 Apr 12, 2021	BUY	$83.5 - $98.47 $124,415 - $146,720	1,490 Added 6.24%	25,354 $2.22 Million
Q4 2020 Feb 10, 2021	BUY	$78.07 - $94.43 $1.57 Million - $1.9 Million	20,100 Added 534.01%	23,864 $2.19 Million
Q3 2020 Nov 06, 2020	SELL	$82.14 - $91.0 $18,235 - $20,202	-222 Reduced 5.57%	3,764 $317,000
Q2 2020 Aug 13, 2020	SELL	$80.93 - $91.1 $85,138 - $95,837	-1,052 Reduced 20.88%	3,986 $350,000
Q1 2020 May 01, 2020	BUY	$70.67 - $99.01 $324,375 - $454,455	4,590 Added 1024.55%	5,038 $448,000
Q1 2020 Apr 27, 2020	SELL	$70.67 - $99.01 $337,590 - $472,970	-4,777 Reduced 91.43%	448 $5.04 Million
Q4 2019 Feb 13, 2020	BUY	$84.35 - $95.37 $31,125 - $35,191	369 Added 7.6%	5,225 $497,000
Q3 2019 Nov 12, 2019	BUY	$85.54 - $94.26 $17,193 - $18,946	201 Added 4.32%	4,856 $429,000
Q2 2019 Aug 15, 2019	BUY	$75.4 - $92.8 $50,819 - $62,547	674 Added 16.93%	4,655 $437,000
Q1 2019 May 08, 2019	BUY	$75.32 - $86.15 $32,688 - $37,389	434 Added 12.24%	3,981 $322,000
Q4 2018 Feb 20, 2019	SELL	$73.66 - $82.02 $23,718 - $26,410	-322 Reduced 8.32%	3,547 $319,000
Q3 2018 Oct 24, 2018	BUY	$66.94 - $77.43 $15,797 - $18,273	236 Added 6.5%	3,869 $337,000
Q2 2018 Aug 20, 2018	BUY	$64.91 - $73.36 $10,061 - $11,370	155 Added 4.46%	3,633 $299,000
Q4 2017 Feb 15, 2018	BUY	$72.33 - $77.64 $15,550 - $16,692	215 Added 6.59%	3,478 $292,000
Q3 2017 Nov 06, 2017	BUY	$74.14 - $77.27 $241,918 - $252,132	3,263	3,263 $270,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Point Advisor Group LLC with notifications on news.

Account

High Point Advisor Group LLC Novartis Ag Transaction History